Your browser doesn't support javascript.
loading
Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population.
Blomberg, Anders; Torén, Kjell; Liv, Per; Granåsen, Gabriel; Andersson, Anders; Behndig, Annelie; Bergström, Göran; Brandberg, John; Caidahl, Kenneth; Cederlund, Kerstin; Egesten, Arne; Ekström, Magnus; Eriksson, Maria J; Hagström, Emil; Janson, Christer; Jernberg, Tomas; Kylhammar, David; Lind, Lars; Lindberg, Anne; Lindberg, Eva; Löfdahl, Claes-Göran; Malinovschi, Andrei; Mannila, Maria; Nilsson, Lars T; Olin, Anna-Carin; Persson, Anders; Persson, Hans Lennart; Rosengren, Annika; Sundström, Johan; Swahn, Eva; Söderberg, Stefan; Vikgren, Jenny; Wollmer, Per; Östgren, Carl Johan; Engvall, Jan; Sköld, C Magnus.
Afiliação
  • Blomberg A; Umea University, Department of Public Health and Clinical Medicine, Umea, Sweden; anders.blomberg@umu.se.
  • Torén K; University of Gothenburg, Section of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, Goteborg, Västra Götaland, Sweden.
  • Liv P; Sahlgrenska University Hospital, Department of Occupational and Environmental Medicine, Goteborg, Sweden.
  • Granåsen G; Umeå University, Department of Public Health and Clinical Medicine, Umea, Sweden.
  • Andersson A; Umeå University, Department of Public Health and Clinical Medicine, Umea, Sweden.
  • Behndig A; Sahlgrenska University Hospital, COPD Center, Department of Respiratory Medicine and Allergology, Goteborg, Sweden.
  • Bergström G; University of Gothenburg, COPD Center, Deparmtent of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, Goteborg, Västra Götaland, Sweden.
  • Brandberg J; Umeå University, Department of Public Health and Clinical Medicine, Umea, Sweden.
  • Caidahl K; University of Gothenburg, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Goteborg, Västra Götaland, Sweden.
  • Cederlund K; Sahlgrenska University Hospital, Department of Clinical Physiology, Goteborg, Sweden.
  • Egesten A; Sahlgrenska University Hospital, Department of Radiology, Goteborg, Sweden.
  • Ekström M; University of Gothenburg, Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, Goteborg, Västra Götaland, Sweden.
  • Eriksson MJ; Karolinska Institute, Department of Clinical Physiology, Stockholm, Stockholm County, Sweden.
  • Hagström E; Karolinska University Hospital, Department of Clinical Physiology, Stockholm, Sweden.
  • Janson C; Sahlgrenska University Hospital, Department of Clinical Physiology, Goteborg, Sweden.
  • Jernberg T; Karolinska Institute, Department of Clinical Science, Intervention and Technology, Stockholm, Sweden.
  • Kylhammar D; Lund University, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden.
  • Lind L; Lund University, Respiratory Medicine, Allergology and Palliative Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund, Sweden.
  • Lindberg A; Karolinska Institute Department of Molecular Medicine and Surgery, Stockholm, Stockholm, Sweden.
  • Lindberg E; Karolinska University Hospital, Department of Clinical Physiology, Stockholm, Sweden.
  • Löfdahl CG; Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden.
  • Malinovschi A; Uppsala University, Uppsala Clinical Research Center, Uppsala, Sweden.
  • Mannila M; Uppsala University, Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala, Sweden.
  • Nilsson LT; Karolinska Institute, Department of Clinical Sciences, Danderyd University Hospital, Stockholm, Sweden.
  • Olin AC; Linköping University, Department of Health, Medicine and Caring Sciences, and Department of Clinical Physiology and Wallenberg Centre for Molecular Medicine, Linkoping, Sweden.
  • Persson A; Uppsala University, Department of Medical Sciences, Clinical Epidemiology, Uppsala, Sweden.
  • Persson HL; Umeå University, Department of Public Health and Clinical Medicine, Umea, Sweden.
  • Rosengren A; Uppsala University, Department of Medical Sciences, Respiratory, Allergy and Sleep research, Uppsala, Sweden.
  • Sundström J; Lund University, Respiratory Medicine, Allergology and Palliative Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund, Sweden.
  • Swahn E; Uppsala University, Department of Medical Sciences, Clinical Physiology, Uppsala, Sweden.
  • Söderberg S; Karolinska University Hospital, Department of Cardiology and Department of Clinical Genetics, Stockholm, Sweden.
  • Vikgren J; Umeå University, Department of Public Health and Clinical Medicine, Umea, Sweden.
  • Wollmer P; University of Gothenburg, Section of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, Goteborg, Västra Götaland, Sweden.
  • Östgren CJ; Linköping University, CMIV Centre of Medical Image Science and Visualization, Linkoping, Östergötland, Sweden.
  • Engvall J; Linköping University, Department of Radiology and Department of Health, Medicine and Caring Sciences, Linkoping, Östergötland, Sweden.
  • Sköld CM; Karolinska Institute, Department of Clinical Sciences, Huddinge University Hospital, Stockholm, Sweden.
Ann Am Thorac Soc ; 2024 Aug 12.
Article em En | MEDLINE | ID: mdl-39133529
ABSTRACT
RATIONALE Chronic obstructive pulmonary disease (COPD) includes respiratory symptoms and chronic airflow limitation (CAL). In some cases, emphysema and impaired diffusing capacity for carbon monoxide (DLCO) are present, but characteristics and symptoms vary with smoking exposure.

OBJECTIVES:

To study the prevalence of CAL, emphysema and impaired DLCO in relation to smoking and respiratory symptoms in a middle-aged population.

METHODS:

We investigated 28,746 randomly invited individuals (52% women) aged 50-64 years across six Swedish sites. We performed spirometry, DLCO, high-resolution computed tomography (HRCT) and asked for smoking habits and respiratory symptoms. CAL was defined as post-bronchodilator forced expiratory volume in 1 second divided by forced expiratory volume (FEV1/FVC)<0.7.

RESULTS:

The overall prevalence was for CAL 8.8%, for impaired DLCO (DLCOemphysema 8.8%, with a higher prevalence in current smokers than in ex-smokers and never-smokers. The proportion of never-smokers among those with CAL, emphysema and impaired DLCO was 32%, 19% and 31% respectively. Regardless of smoking habits, the prevalence of respiratory symptoms was higher among people with CAL and impaired DLCO, compared to those with normal lung function. Asthma prevalence in never-smokers with CAL was 14%. In this group, asthma associated with lower FEV1 and more respiratory symptoms.

CONCLUSIONS:

In this large population-based study of middle-aged people, CAL and impaired DLCO were associated with common respiratory symptoms. Self-reported asthma was not associated with CAL in never-smokers. Our findings suggest that CAL in never-smokers signifies a separate clinical phenotype that may be monitored and, possibly, treated differently from smoking-related COPD. This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https//creativecommons.org/licenses/by/4.0/).

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article